Danaher Corporation
Rating
Updated: Sep 1, 2026Why Price Moved
Shares are down as Danaher's revenue outlook cut a...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commer...
Latest News
6 days ago · prnewswire.com
Danaher Announces Quarterly DividendWASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 30, 2026 to holders of record on September 30, 2026.
6 days ago · zacks.com
ELV or DHR: Which Is the Better Value Stock Right Now?Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
28 days ago · zacks.com
Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.
1 month ago · defenseworld.net
BlackRock Inc. Acquires Shares of 55,084,630 Danaher Corporation $DHRBlackRock Inc. acquired a new position in Danaher Corporation (NYSE: DHR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 55,084,630 shares of the conglomerate's stock, valued at approximately $10,492,520,000. BlackRock Inc. owned 7.84% of Danaher as of its
1 month ago · defenseworld.net
13,061,264 Shares in Danaher Corporation $DHR Acquired by BlackRock Inc.BlackRock Inc. acquired a new stake in Danaher Corporation (NYSE: DHR) during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 13,061,264 shares of the conglomerate's stock, valued at approximately $9,404,633,000. BlackRock Inc. owned approximately 1.86% of Danaher at the end of the most recent quarter.
1 month ago · seekingalpha.com
Danaher: 2027 Growth Reacceleration Should Drive UpsideDanaher is rated a Buy, with revenue growth expected to accelerate in 2027 as respiratory headwinds fade and bioprocessing shipments recover. DHR's valuation is reasonable, trading at a 12% discount to its five-year average P/E, supported by strong recurring revenues and operational excellence. Life Sciences segment shows robust recovery, with 5.5% core growth and margin expansion, driven by improved pharma spending and biotech funding.
2 months ago · prnewswire.com
Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive OfficerRainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a senior advisor until March 31, 2027 to ensure a seamless transition.
2 months ago · zacks.com
Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Danaher (DHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
2 months ago · barrons.com
Don't Quit on Danaher Stock After Horrific Earnings ReactionThere's reason to believe the stock can stage a comeback after its worst day in two decades.
2 months ago · defenseworld.net
Danaher Corporation $DHR Stake Raised by Andra AP fondenAndra AP fonden raised its holdings in shares of Danaher Corporation (NYSE: DHR) by 648.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 76,642 shares of the conglomerate's stock after buying an additional 66,405 shares during the period. Andra AP fonden's holdings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove DHR